Premium
Survival of the fetus during maternal thoracotomy under cardiopulmonary bypass for infective endocarditis
Author(s) -
Luo Li,
Sun Qiulei,
Chen Liping,
Ying Demei,
Wu Xiaohua,
Chen Zhengqiong
Publication year - 2017
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.13414
Subject(s) - medicine , cardiopulmonary bypass , fetus , perioperative , pregnancy , thoracotomy , infective endocarditis , regurgitation (circulation) , surgery , gestation , cardiology , genetics , biology
Infective endocarditis (IE) during pregnancy is a rare but serious condition. Cardiopulmonary bypass during pregnancy has a high rate of fetal morbidity and mortality. We here report the case of a 22‐year‐old pregnant woman with confirmed IE. Multiple large cardiac valve vegetations, severe aortic valve regurgitation, and hemodynamic compromise were observed. With full implementation of fetal monitoring and protection strategies, open heart surgery was performed at 31.4 weeks’ gestation to aid survival, followed by an elective cesarean delivery at 34.4 weeks. As of the 3‐month follow‐up, both the mother and infant were in good health. This shows that a fetus can survive maternal thoracotomy under cardiopulmonary bypass with proper perioperative management, which means that this technique does not need to be excluded from consideration in the treatment of IE complicating pregnancy.